Fortinskaia E S, Torkhovskaia T I, Nalivaĭko E S, Kliuchnikova Zh I, Khalilov E M
Vopr Med Khim. 1989 Mar-Apr;35(2):109-12.
Activity of lecithine-cholesterol acyltransferase (LCAT) was studied in blood of 26 patients with atherosclerosis of various localization after course of treatment involving three-fold hemosorption. The initial activity of the enzyme, decreased distinctly as compared with normal state, was dissimilarly altered during hemosorption. The system LCAT-HDLP was stabilized after the third hemosorption. These results relevant to programming hemosorption therapy of patients with atherosclerosis.
对26例不同部位动脉粥样硬化患者在进行三次血液吸附治疗后的血液中卵磷脂胆固醇酰基转移酶（LCAT）的活性进行了研究。与正常状态相比，该酶的初始活性明显降低，在血液吸附过程中变化各异。第三次血液吸附后，LCAT-HDLP系统趋于稳定。这些结果与动脉粥样硬化患者血液吸附治疗的方案制定相关。
